Two U.S.-based researchers aiming to help gene-corrected airway stem cells grow and survive long enough to repair lung tissue — with…
Margarida Maia, PhD
Margarida is a biochemist (University of Porto, Portugal) with a PhD in biomedical sciences (VIB and KULeuven, Belgium). Her main interest is science communication. She is also passionate about design and the dialogue between art and science.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Margarida Maia, PhD
Continued treatment with CFTR modulators was linked to lower anxiety and depression scores in children with cystic fibrosis…
Children with cystic fibrosis (CF) who were using CFTR modulators had lower anxiety scores than those not using the…
Cystic fibrosis (CF) likely affects as many babies in parts of Asia, Africa, and South America as in Europe…
Adults with cystic fibrosis (CF) who are better at coping with their thoughts and feelings also achieve greater well-being,…
Delivering gene-editing tools to mice while they were still developing in the womb corrected the mutated CFTR gene that causes…
Adding the experimental treatment CMTX-101 to standard antibiotics reduced the number of Pseudomonas aeruginosa — a type of bacteria…
While most adults with cystic fibrosis (CF) view their health as very good or excellent while on Kalydeco…
Using inhaled antibiotics can help control the growth of certain bacteria in the lungs, but it may increase the risk of fungal…
In young children with cystic fibrosis (CF), infections with methicillin-resistant Staphylococcus aureus (MRSA) are linked to more antibiotic use,…